Hagan Joseph P Insider Trades

Insider Trading History

Track insider trading activity for Hagan Joseph P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.37M 291,000 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $2.13M 260,808 shares
Last Trade
Jan 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.5k 50,000 shares
$1.09
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $11M 1,350,000 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 1,350,000 shares
$1.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $1.72M 210,808 shares
Last Trade
Jan 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.8k 11,764 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $1.82M 222,572 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$145k 115,290 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $2.76M 337,862 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$379k 280,750 shares
$1.35
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $8.08M 990,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.99M 990,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $466k 57,112 shares
Last Trade
Jan 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.4k 14,580 shares
$1.19
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Executive Officer
Holding Value $2.03M 249,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 249,000 shares
$1.30
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $10.7M 1,312,500 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 1,312,500 shares
$1.36
$8.16
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $196k 11,961 shares
Last Trade
May 19, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.88k 272 shares
$10.58
$16.37
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $200k 12,233 shares
Last Trade
May 18, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.8k 8,733 shares
$10.74
$16.37
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $0 0 shares
Last Trade
May 18, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.8k 8,733 shares
$10.74
$16.37
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $816k 100,000 shares
Last Trade
Jan 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 100,000 shares
$1.48
$8.16
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $239k 14,612 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$164k 14,612 shares
$11.21
$16.37
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $2.45M 300,000 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$515k 300,000 shares
$1.72
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $3.4M 417,006 shares
Last Trade
Jan 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$215k 100,000 shares
$2.15
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $13.1M 1,600,000 shares
Last Trade
Jan 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 1,600,000 shares
$2.57
$8.16
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $712k 43,500 shares
Last Trade
Jan 03, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$899k 40,000 shares
$22.48
$16.37
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $164k 10,000 shares
Last Trade
Jan 03, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$899k 40,000 shares
$22.48
$16.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up